What drove ALSAF.PA stock down in pre-market trading?

ALSAF.PA stock fell due to elevated selling, weak liquidity metrics (current ratio 0.03) and market concern over enterprise value versus market cap. Heavy volume of 18,778.00 amplified the move.

What is Meyka AI's forecast for ALSAF.PA stock?

Meyka AI's forecast model projects a monthly price of EUR 1.06 and a quarterly price of EUR 1.03, implying upside of 21.84% and 18.39% from EUR 0.87. Forecasts are not guarantees.

Should I trade ALSAF.PA stock now?

Trading ALSAF.PA stock suits short-term, risk-tolerant traders due to volatility and liquidity issues. Long-term investors should wait for clear balance-sheet improvements or capital plan disclosure.

Where can I find official company information for ALSAF.PA?

Safe Orthopaedics’ official site provides corporate updates and product info. Check investor pages for filings and press releases before making decisions.

EU Stocks

ALSAF.PA Safe Orthopaedics Euronext pre-market 10 Feb 2026: -9.37% as cash risk

ByDanny Kontos February 10, 2026

ALSAF.PA stock opened the Euronext pre-market session down 9.37% to EUR 0.87 on 10 Feb 2026, after a slide from a previous close of EUR 0.96. Trading volume is elevated at 18,778.00 shares versus an average of 7,340.00, signaling outsized selling. The fall follows mixed operational metrics and a very stretched balance sheet, making liquidity and cash runway immediate investor concerns. We summarise key metrics, technicals, Meyka AI grading, and price forecasts to help investors weigh short-term downside against possible recovery scenarios.